medscape.com
Cure8 news brief
Why This Matters
The study highlights racial and ethnic disparities in access to IBD care — including specialist visits, use of advanced therapies, and emergency services — which can affect disease management and outcomes. Recognizing these gaps can inform efforts to improve equity in IBD care delivery.
Who Should Pay Attention
Adult patients with IBD (especially Asian, Hispanic, and Black American patients), caregivers, gastroenterologists, health services researchers, and policymakers focused on health equity.
Study Snapshot
Story typeResearch news
Evidence typeObservational study
Source depthFull source text
What To Know
The article reports differences in how often people from different racial and ethnic groups accessed IBD care — including visits to gastroenterologists, use of advanced therapies, steroid prescribing, emergency visits, hospitalizations, and diagnostic procedures.
The authors highlight access and equity concerns and call for further research and policy work to address disparities.
How this might affect patients: If you belong to a historically marginalized group or care for someone who does, this study raises concerns that access to specialists, advanced treatments, and outpatient care may be lower and emergency care use higher for some groups. It does not provide individual treatment recommendations or change clinical guidance.
Source note: The underlying research was published in The American Journal of Gastroenterology and analyzed large claims datasets; the Medscape article summarizes those results for a clinical audience.
Keep In Mind
This was an observational claims-based study with limitations including race/ethnicity classification methods, exclusion of some insured groups (Medicaid under‑65), and analyses limited to a single year for utilization measures. The article is a news summary of the peer-reviewed study and does not change clinical recommendations.
Source Details
Review the original publication for the complete reporting, methods, and context.
Publicationmedscape.com
Indexed viaBing News
Source typeResearch news
PublishedApr 18, 2025, 4:11 AM
Content availableFull source text
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
estimating the uk population cost of crohn's disease and ulcerative colitis using a ... - Springer Nature
This study quantifies the large NHS and societal costs of Crohn’s disease and ulcerative colitis in the UK and highlights that ongoing management and maintaining remission are major drivers of expense.
India needs patient-centric care and trained counsellors to manage Inflammatory Bowel Diseases burden: experts
Rising IBD cases, limited specialist access, and cultural differences in decision-making may delay diagnosis, worsen outcomes, and increase misinformation.
TIME-trend and forecasting of the economic impact of inflammatory bowel disease in Catalonia: a population-based analysis.
The study shows rapidly rising IBD healthcare costs driven mainly by growing prevalence and biologic therapy spending, which can affect access, insurance coverage, and healthcare planning for people with Crohn’s and...